| (USD millions) | | H1 2020 | | H1 2019 | |
|
| Property, plant and equipment | | 26 | | 44 | |
|
| Right-of-use assets | | 32 | | | |
|
| Currently marketed products | | 269 | | | |
|
| Acquired research and development | | 8 602 | | 449 | |
|
| Deferred tax assets | | 470 | | 20 | |
|
| Financial and other assets | | 49 | | | |
|
| Inventories | | 84 | | 6 | |
|
| Trade receivables, marketable securities
and other current assets | |
109 | |
4 | |
|
| Cash and cash equivalents | | 76 | | | |
|
| Deferred tax liabilities | | – 1 928 | | – 101 | |
|
| Current and non-current financial debts | | – 32 | | – 2 | |
|
| Current and non-current lease liabilities | | – 44 | | | |
|
| Trade payables and other liabilities | | – 144 | | – 9 | |
|
| Net identifiable assets acquired | | 7 569 | | 411 | |
|
| Acquired cash and cash equivalents | | – 76 | | | |
|
| Goodwill | | 2 537 | | 75 | |
|
| Net assets recognized as a result of business combinations | | 10 030 | | 486 | |
|